Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017168 (
gastroesophageal reflux disease
)
11,783
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A retrospective case-note analysis was undertaken of 47 children with a congenital upper motor neurone bulbar palsy (excluding pure speech dyspraxia) to clarify the phenotype of Worster-Drought syndrome (WDS) and to record its associated features and complications. The results revealed that the study children had significant bulbar problems (with 80% still needing a modified diet and a similar number using augmentative communication methods at last review). There were also high rates of predictable bulbar complications (86% had dribbling, 60% had
glue ear
, gastro-
oesophageal reflux
in 40%, history of poor nutrition in 40% and aspiration in 40%). Most of the children had additional complex impairments (91% had mild pyramidal tetraplegia, 81% learning difficulties, 60% congenital defects, 41% neuropsychiatric problems and 28% epilepsy). Over half of the children had significant medical problems in the first year, but mean age at diagnosis was 6 years. There were no obvious causes in pregnancy or birth. Six children had a family history of WDS and 32% (12/37) had abnormal neuroimaging including five with bilateral perisylvian polymicrogyria. In our experience, WDS is not uncommon, is relatively easily diagnosed and is crucial not to miss as the management of these children's multiple impairments is complex and requires a careful team approach. WDS falls clearly within the cerebral palsies as a syndrome that includes motor impairment arising from static damage to the brain in early life. The common presence of cognitive, behavioural and seizure impairments strongly supports the cerebral cortical (presumably perisylvian) localization. Its core elements are a suprabulbar paresis, a mild spastic tetraplegia and a significant excess of cognitive and behavioural impairments and epilepsy. The complete overlap in phenotype between WDS and the bilateral perisylvian syndrome leads us to propose that they are the same condition. WDS is startlingly absent from epidemiological studies of the cerebral palsies and rarely diagnosed, presumably because of lack of clinical awareness of the condition and lack of major gross motor impairments.
...
PMID:Worster-Drought syndrome, a mild tetraplegic perisylvian cerebral palsy. Review of 47 cases. 1100 32
Otitis media with effusion
(OME) is a common and important condition that may result in developmental delay in children, and significant health care resources are devoted to its management. Newer techniques including polymerase chain reaction are implicating organisms not previously considered important in etiology. The role of
gastroesophageal reflux
as a cause of OME is likely to receive greater research attention. Regarding prevention, more is being learned about potentially modifiable risk factors such as environmental smoke, care outside the home, and breast feeding. Although immunization may to play a role in the future, existing evidence suggests that the general population of children should not be immunized in order to prevent OME. Several major studies have recently added to the understanding of epidemiology and management. Large trials in the United States, the Netherlands, and the UK suggest that OME is not an appropriate condition to include in a screening program. In addition, the advantages of early treatment with ventilation tubes over watchful waiting in terms of language development tend be modest and diminish by about 18 months. Treatment with hearing aids should be further evaluated. The search for effective medical management continues, and better ways are being identified of targeting interventions to those children with OME who are most likely to benefit.
...
PMID:The Etiology, Pathophysiology, and Management of Otitis Media with Effusion. 1276 Aug 17
Otitis media with effusion
(OME) is one of the most often diagnosed diseases in the pre-school children. OME is defined as the presence of effusion behind the intact tympanic memebrane without symptoms of acute infection. Pathogenesis of OME is multifactorial and represents the interactions between environmental, social, anatomical and infectious factors and an allergy. Due to the hearing impairment accompanying this disease, effective prevention and treatment are necessary. This publication presents current knowledge concerning etiopathogenesis of OME taking into consideration the role of Eustachian tube, infectious factor, allergy, immunological factors, NO and
gastroesophageal reflux disease
. Recommended methods of treatment depending on the clinical condition and the age of children are also presented. The initiation of appropriate therapy is crucial because of the possibility of remote complications.
...
PMID:[Current opinions on pathogenesis and treatment of otitis media with effusion in children]. 1726 39
Otitis media with effusion
(OME), a kind of inflammatory disease of the middle ear, is characterized by the retention of middle ear effusions and hearing loss. There are many factors involved in the development of OME including bacterial infection, formation of bacterial biofilms, eustachian tube dysfunction, adenoid hypertrophy, immune system disorders. Recently, some studies showed that
gastroesophageal reflux
has correlation with OME.
...
PMID:[Gastroesophageal reflux and otitis media with effusion]. 2667 55
International consensus on the treatment of pediatric otitis media with effusion and current status of treatment in China Summary
Otitis media with effusion
(OME) is a non-suppurative inflammatory disease of the middle ear characterized by
middle ear effusion
and hearing loss, which is common in children.The main impact of OME in children is hearing loss and cooccurring recurrent acute otitis media, which would affect speech language development. Thus OME should be highly vigilant and prompt treatment is necessary. There have been many guidelines and evidence-based medicine research on the diagnosis and treatment of OME in children. But there is still no unified conclusion. International Federation of Otorhinolaryngological Societies Congress(IFOS) published an international consensus on the diagnosis and treatment of OME in children in 2017 to promote the standardized diagnosis and treatment of the disease. The guidelines suggest that
gastroesophageal reflux
and allergy should be routinely evaluated in children with OME. Children should be routinely evaluated by hearing tests. Steroids, antibiotics, and decongestants are not recommended because they have no evidence of definite efficacy and could cause side effects. Patients with ineffective conservative treatment should undergo myringotomy, and children over 4 years old should also consider adenoidectomy.
...
PMID:[International consensus on the treatment of pediatric otitis media with effusion and current status of treatment in China]. 3040 Jun 96
Otitis media with effusion
(OME) is a frequent paediatric disorder. The condition is often asymptomatic, and so can easily be missed. However, OME can lead to hearing loss that impairs the child's language and behavioural development. The diagnosis is essentially clinical, and is based on otoscopy and (in some cases) tympanometry. Nasal endoscopy is only indicated in cases of unilateral OME or when obstructive adenoid hypertrophy is suspected.
Otitis media with effusion
is defined as the observation of middle-ear effusion at consultations three months apart. Hearing must be evaluated (using an age-appropriate audiometry technique) before and after treatment, so as not to miss another underlying cause of deafness (e.g. perception deafness). Craniofacial dysmorphism, respiratory allergy and gastro-
oesophageal reflux
all favour the development of OME. Although a certain number of medications (antibiotics, corticoids, antihistamines, mucokinetic agents, and nasal decongestants) can be used to treat OME, they are not reliably effective and rarely provide long-term relief. The benchmark treatment for OME is placement of tympanostomy tubes (TTs) and (in some cases) adjunct adenoidectomy. The TTs rapidly normalize hearing and effectively prevent the development of cholesteatoma in the middle ear. In contrast, TTs do not prevent progression towards tympanic atrophy or a retraction pocket. Adenoidectomy enhances the effectiveness of TTs. In children with adenoid hypertrophy, adenoidectomy is indicated before the age of 4 but can be performed later when OME is identified by nasal endoscopy. Children must be followed up until OME has disappeared completely, so that any complications are not missed.
...
PMID:Otitis media with effusion in children: Pathophysiology, diagnosis, and treatment. A review. 3122 99